Daiwa Securities Group Inc. Senseonics Holdings, Inc. Transaction History

Daiwa Securities Group Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$1.71 - $4.14 $26,163 - $63,341	-15,300 Closed	0 $0
Q1 2021 May 03, 2021	SELL	$0.85 - $5.27 $105,315 - $652,953	-123,900 Reduced 89.01%	15,300 $40,000
Q4 2020 Feb 04, 2021	SELL	$0.36 - $0.95 $12,888 - $34,010	-35,800 Reduced 20.46%	139,200 $121,000
Q1 2020 May 14, 2020	SELL	$0.56 - $1.62 $238,000 - $688,500	-425,000 Reduced 70.83%	175,000 $110,000
Q4 2019 Jan 31, 2020	SELL	$0.83 - $1.3 $15,206 - $23,817	-18,321 Reduced 2.96%	600,000 $549,000
Q3 2019 Nov 04, 2019	BUY	$0.97 - $1.94 $454,271 - $908,542	468,321 Added 312.21%	618,321 $611,000
Q2 2019 Jul 24, 2019	BUY	$1.81 - $2.45 $45,250 - $61,250	25,000 Added 20.0%	150,000 $306,000
Q1 2019 Apr 26, 2019	BUY	$2.3 - $3.27 $57,499 - $81,750	25,000 Added 25.0%	125,000 $306,000
Q4 2018 Feb 05, 2019	BUY	$2.49 - $4.54 $89,889 - $163,894	36,100 Added 56.49%	100,000 $259,000
Q3 2018 Nov 01, 2018	SELL	$3.4 - $4.84 $58,140 - $82,764	-17,100 Reduced 21.11%	63,900 $304,000
Q2 2018 Jul 30, 2018	BUY	$3.03 - $4.98 $245,429 - $403,380	81,000 New	81,000 $332,000

140

59.9M

393K

254K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $363M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.